Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs morphine for analgesia and PONV in high-risk laparoscopic cholecystectomy
ChiCTR2600125123Phase 4Not yet recruiting
- Sponsor
- Liyang People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Liyang People's Hospital. Primary endpoint: Postoperative 24-hour PONV incidence. Planned start May 2026; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600125123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125123.